News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
1Bitget UEX Daily | Trump Pledges to Safeguard Crude Oil Transport; Oil Prices Surge and Pull Back; Gold and Silver Plunge as Dollar Strengthens (March 04, 2026)2Locals prefer satoshis to dollars, says Africa Bitcoin chair Stafford Masie3'No longer a choice': Bitwise CIO says US-Iran strikes put crypto in primary market role
Wall St futures edge higher following news of Iran-US negotiations aimed at resolving conflict
101 finance·2026/03/04 12:36
Stablecoins will stay, but only if built right
Cointelegraph·2026/03/04 12:33
Cardano Creator Says XRP Might Get a Free Pass. Here’s why
TimesTabloid·2026/03/04 12:33
3 Reasons Why You Should Steer Clear of FLG and One Alternative Stock Worth Buying
101 finance·2026/03/04 12:33
Q4 Top Earnings Performers: Fiserv (NASDAQ:FISV) and Other Leading Payment Processing Stocks
101 finance·2026/03/04 12:24
Bear Pick for Today: Bassett Furniture (BSET)
101 finance·2026/03/04 12:18
TSX futures rise as oil, gold climb amid ongoing Iran conflict
Investing.com·2026/03/04 12:18
USD/JPY: Backed by safe haven demand and BoJ outlook – Rabobank
101 finance·2026/03/04 12:18
Chart analysts warn of potential S&P 500 pullback as conflict concerns rise
101 finance·2026/03/04 12:15
Life Sciences Tools & Services Stocks Fourth Quarter Review: Comparing PacBio (NASDAQ:PACB)
101 finance·2026/03/04 12:15
Flash
12:34
Altisource Portfolio Solutions SA announces its financial outlook for fiscal year 2026The company expects that service revenue will reach a range of $165 million to $185 million by then. Meanwhile, the target for adjusted EBITDA is set between $15 million and $20 million.
12:34
The latest financial data from biotechnology company Tscan Therapeutics, Inc. shows that its current cash and cash equivalents are sufficient to support the company's daily operations and R&D investment through the second half of 2027.This capital reserve provides the company with stable financial support for advancing the development of tumor-targeted therapies, demonstrating the enterprise's robust approach to capital management.
12:34
Renowned investment research firm Telsey Advisory Group has released its latest report, upgrading the investment rating of discount retailer Ross Stores Inc from "Market Perform" to "Outperform".At the same time, the institution has significantly raised its target share price from the previous $220 to $240, demonstrating strong confidence in the company's future performance growth. This rating adjustment reflects analysts' recognition of Ross Stores' core competitiveness. Through efficient supply chain management and precise product selection strategies, the company continues to maintain a leading position in the discount retail sector. The upward revision of the target price suggests that the institution expects the stock price to have about 9% upside potential.
Trending news
MoreWall St futures edge higher following news of Iran-US negotiations aimed at resolving conflict
The latest financial data from biotechnology company Tscan Therapeutics, Inc. shows that its current cash and cash equivalents are sufficient to support the company's daily operations and R&D investment through the second half of 2027.
News